In 2022, Adli Tissue Regeneration Ltd. was founded and leveraged the technical expertise of its founders to initiate activities in medical engineering, polymer engineering, and biotechnology. The primary objective of the organization is to manufacture individualized implants and surgical meshes with osseointegration capacity for patients with bone defects.